Delivery Order SPE2DB22D3004-SPE2DB24FQD32
- Not listed
- This is a $2,259.62 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract provides for the procurement of Pfizer COVID-19 vaccine doses over a 4-year period from 2024 to 2025, with an ultimate completion date of January 17, 2025. The award was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has an...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,525.97 contract is for the delivery of Pfizer COVID-19 vaccine doses over a period of 6 months to 4 years. The contract is a Firm Fixed Price type with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with expertise in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,135.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses in 0.9 mL vials. The contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,227.33, is for the delivery of Pfizer COVID-19 vaccine doses with a 6-month to 4-year shelf life under the Emergency Use Authorization (EUA). The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses. The $1,081.35 award is for an estimated 0.9 ml doses to be delivered by January 4, 2024. Amerisourcebergen is a prime contractor that has previously supplied pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. This order is not associated with a...
- This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,525.97 firm-fixed-price contract is for the supply of the Pfizer COVID-19 vaccine under the Emergency Use Authorization (EUA) for the 2023-2024 period, with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines from 2024 to 2025, with an ultimate completion date of February 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order valued at $1,622.03, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines and related medical products, including 0.9ML vials, to support military healthcare programs from 2024 to 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a $1,525.97 firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of 4564810010 - PFIZER COVID 2023-24(6M-4Y)EUA 0.9ML pharmaceutical products, with a period of performance ending on June 6, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccine doses to support vaccine requirements from 2024 to 2025, with a potential treatment window of 6 months to 4 years. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQD32Delivery Order
This is a $1,739.24 Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Pfizer COVID-19 vaccines (0.9ml) during the period of June 2023 to April 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a range of medications and critical care materials to support the Department of Defense's medical treatment programs worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/25/24 |